Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HucMSCs Transplantation for Acute Cerebral Infarction
NCT04093336Phase 2Unknown
- Sponsor
- Shanghai East Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in ischemic stroke (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Adverse Events at 24 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04093336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04093336.